These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26709764)

  • 1. Molecular mechanisms in differentiated thyroid cancer.
    Xie J; Fan Y; Zhang X
    Front Biosci (Landmark Ed); 2016 Jan; 21(1):119-29. PubMed ID: 26709764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis.
    Vasko VV; Saji M
    Curr Opin Oncol; 2007 Jan; 19(1):11-7. PubMed ID: 17133106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology of differentiated thyroid cancer.
    Greco A; Borrello MG; Miranda C; Degl'Innocenti D; Pierotti MA
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):440-53. PubMed ID: 19910897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
    Sohn SY; Park WY; Shin HT; Bae JS; Ki CS; Oh YL; Kim SW; Chung JH
    Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
    Acquaviva G; Visani M; Repaci A; Rhoden KJ; de Biase D; Pession A; Giovanni T
    Histopathology; 2018 Jan; 72(1):6-31. PubMed ID: 29239040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.
    Shakib H; Rajabi S; Dehghan MH; Mashayekhi FJ; Safari-Alighiarloo N; Hedayati M
    Endocrine; 2019 Dec; 66(3):435-455. PubMed ID: 31378850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNAs in endocrine cancer metastasis.
    Lima CR; Gomes CC; Santos MF
    Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene profile of papillary thyroid carcinoma.
    Sugg SL; Ezzat S; Zheng L; Freeman JL; Rosen IB; Asa SL
    Surgery; 1999 Jan; 125(1):46-52. PubMed ID: 9889797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.
    Veschi V; Verona F; Lo Iacono M; D'Accardo C; Porcelli G; Turdo A; Gaggianesi M; Forte S; Giuffrida D; Memeo L; Todaro M
    Front Endocrinol (Lausanne); 2020; 11():566. PubMed ID: 32982967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
    Vuong HG; Altibi AM; Duong UN; Ngo HT; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
    Tumour Biol; 2017 Oct; 39(10):1010428317713913. PubMed ID: 29037127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.
    Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J
    Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?
    Sugg SL; Zheng L; Rosen IB; Freeman JL; Ezzat S; Asa SL
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3360-5. PubMed ID: 8784097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and metastasis: small RNAs play big roles.
    Kim J; Yao F; Xiao Z; Sun Y; Ma L
    Cancer Metastasis Rev; 2018 Mar; 37(1):5-15. PubMed ID: 29234933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
    Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
    Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of TGFβ signaling and microRNA in thyroid cell loss of differentiation and cancer progression.
    Fuziwara CS; Saito KC; Kimura ET
    Arch Endocrinol Metab; 2019; 63(5):536-544. PubMed ID: 31482959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.
    Ciampi R; Romei C; Pieruzzi L; Tacito A; Molinaro E; Agate L; Bottici V; Casella F; Ugolini C; Materazzi G; Basolo F; Elisei R
    J Endocrinol Invest; 2017 Jan; 40(1):55-62. PubMed ID: 27535135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
    Albarel F; Conte-Devolx B; Oliver C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.
    Ricarte-Filho JC; Ryder M; Chitale DA; Rivera M; Heguy A; Ladanyi M; Janakiraman M; Solit D; Knauf JA; Tuttle RM; Ghossein RA; Fagin JA
    Cancer Res; 2009 Jun; 69(11):4885-93. PubMed ID: 19487299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.